Delivery Order SPE2DB20D1100-SPE2DB25FD3G8

Award Date 7/9/25
Potential Completion Date 7/10/25
Potential Value $5.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and a Ceiling Value of $2,728.16. The contract is for the delivery of REMIFENTANIL 2 MG VIALS and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,667.30, is for the delivery of REMIFENTANIL 1 MG VIALS, a specialty medication. It is a firm fixed-price delivery order contract with a completion date of December 31, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of REMIFENTANIL 1 MG VIALS. The delivery order contract, valued at $5,149.43, has a firm fixed price and is set to expire on October 22, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth...
This federal contract award, valued at $3,629.36, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REMIFENTANIL 1 MG VIALS, a critical pharmaceutical product, with a completion date of February 20, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of REMIFENTANIL 5 MG VIALS. The $46,065.69 fixed-price delivery order contract has a completion date of June 17, 2025 and was awarded on June 16, 2025 by the Defense Logistics Agency (DLA), a defense agency. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of REMIFENTANIL 1 MG VIALS, a specialty medication, with a ceiling value of $2,270.35 and a completion date of April 3, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $1,063.41 for the supply of REMIFENTANIL 1 MG VIALS. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of October 22, 2024. The contract is a Firm Fixed Price arrangement, and no set-aside designation was used. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,731.19 Firm Fixed Price delivery order contract is for the supply of REMIFENTANIL 2 MG VIALS, a specialty medication. The contract has an ultimate completion date of April 3, 2025 and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen holds a $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Remifentanil 1 mg vials. The contract has a ceiling value of $1,755.60 and a period of performance through October 31, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of REMIFENTANIL 1 MG VIALS. The contract has a ceiling value of $3,667.30 and is a firm-fixed price contract with a completion date of June 24, 2025. The contract is not set-aside and was awarded on June 23, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FD3G8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of REMIFENTANIL 1 MG VIALS, with a Ceiling Value of $5,867.68 and a Firm Fixed Price pricing type. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and no subcontractors are mentioned. The contract has an Ultimate Completion Date of July 10, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 10/8/25, 10:47 AM